Sustained‐release dexamethasone for the treatment of ocular inflammation and pain after cataract surgery

[1]  J. Erie,et al.  Increasing incidence of cataract surgery: Population‐based study , 2013, Journal of cataract and refractive surgery.

[2]  S. Takach,et al.  Sustained Delivery of Travoprost from a Biodegradable Hydrogel Punctum Plug for the Treatment of Glaucoma , 2013 .

[3]  Ankita R. Desai,et al.  Pharmacokinetics Demonstrating Sustained Dexamethasone Delivery from a Punctum Plug in a Canine Model , 2013 .

[4]  Cheryl A. Arcinue,et al.  A comparison between the fluocinolone acetonide (Retisert) and dexamethasone (Ozurdex) intravitreal implants in uveitis. , 2013, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

[5]  E. Soriano,et al.  Intracapsular dexamethasone implant in patients undergoing phacoemulsification and intraocular lens implantation. , 2013, Arquivos brasileiros de oftalmologia.

[6]  S. Chee.  Moxifloxacin punctum plug for sustained drug delivery. , 2012, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

[7]  T. Oetting,et al.  Cataract surgery practice patterns in the United States Veterans Health Administration , 2012, Journal of cataract and refractive surgery.

[8]  L. Jost,et al.  Corticosteroid Delivery from a Punctum Plug in a Canine Model Over 21-Days , 2012 .

[9]  D. Chang,et al.  Risk factors for steroid response among cataract patients , 2011, Journal of cataract and refractive surgery.

[10]  C. Zetterström,et al.  Intraocular lens as a drug delivery system for dexamethasone , 2010, Acta ophthalmologica.

[11]  J. Tsai.  A comprehensive perspective on patient adherence to topical glaucoma therapy. , 2009, Ophthalmology.

[12]  G. Cervantes-Coste,et al.  Inhibition of surgically induced miosis and prevention of postoperative macular edema with nepafenac , 2009, Clinical ophthalmology.

[13]  R. Crockett,et al.  Difluprednate ophthalmic emulsion 0.05% for postoperative inflammation and pain , 2009, Journal of cataract and refractive surgery.

[14]  P. J. Murphy,et al.  Measurement of ocular surface irritation on a linear interval scale with the ocular comfort index. , 2007, Investigative ophthalmology & visual science.

[15]  E. Holland,et al.  Bromfenac ophthalmic solution 0.09% (Xibrom) for postoperative ocular pain and inflammation. , 2007, Ophthalmology.

[16]  Satish S. Modi,et al.  Nepafenac ophthalmic suspension 0.1% for the prevention and treatment of ocular inflammation associated with cataract surgery , 2007, Journal of cataract and refractive surgery.

[17]  E. Stefánsson,et al.  Comparison of topical 0.7% dexamethasone–cyclodextrin with 0.1% dexamethasone sodium phosphate for postcataract inflammation , 2006, Graefe's Archive for Clinical and Experimental Ophthalmology.

[18]  D. Broadway,et al.  Corticosteroid-induced glaucoma: a review of the literature , 2006, Eye.

[19]  Douglas A Jabs,et al.  Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. , 2005, American journal of ophthalmology.

[20]  P. Aspinall,et al.  Safety and efficacy of a dexamethasone anterior segment drug delivery system in patients after phacoemulsification , 2004, Journal of cataract and refractive surgery.

[21]  C. Laurell,et al.  Effects of dexamethasone, diclofenac, or placebo on the inflammatory response after cataract surgery , 2002, The British journal of ophthalmology.

[22]  H. Hayashi,et al.  Effect of cataract surgery on intraocular pressure control in glaucoma patients , 2001, Journal of cataract and refractive surgery.

[23]  H. Struck,et al.  Comparison of 0.1% dexamethasone phosphate eye gel (Dexagel) and 1% prednisolone acetate eye suspension in the treatment of post-operative inflammation after cataract surgery , 2001, Graefe's Archive for Clinical and Experimental Ophthalmology.

[24]  D. Chang,et al.  Phase II results of an intraocular steroid delivery system for cataract surgery. , 1999, Ophthalmology.

[25]  D. Tan,et al.  Randomized clinical trial of a new dexamethasone delivery system (Surodex) for treatment of post-cataract surgery inflammation. , 1999, Ophthalmology.

[26]  E. Brown,et al.  The Medical Dictionary for Regulatory Activities (MedDRA) , 1999, Drug safety.

[27]  C E Letocha,et al.  The American Academy of Ophthalmology. , 1996, Archives of ophthalmology.

[28]  M. Lemp.  Report of the National Eye Institute/Industry workshop on Clinical Trials in Dry Eyes. , 1995, The CLAO journal : official publication of the Contact Lens Association of Ophthalmologists, Inc.

[29]  A. Flach,et al.  The effect of ketorolac tromethamine in reducing postoperative inflammation: double-mask parallel comparison with dexamethasone. , 1989, Annals of ophthalmology.

[30]  Andrew D. Dick,et al.  The standardization of uveitis nomenclature (SUN) working group; standardization of uveitis nomenclature for reporting clinical data: Results of the first international workshop , 2005 .

[31]  W. Konen,et al.  Effect of dexamethasone 0.1% and prednisolone acetate 1.0% eye drops on the blood-aqueous barrier after cataract surgery: a controlled randomized fluorophotometric study , 2004, Graefe's Archive for Clinical and Experimental Ophthalmology.

[32]  R. Bilonick,et al.  Dovepress Open Access to Scientific and Medical Research Open Access Full Text Article Intracameral Dexamethasone Reduces Inflammation on the First Postoperative Day after Cataract Surgery in Eyes with and without Glaucoma , 2022 .